Friday, July 10, 2026

pharma · Early Childhood Caries · Acute Myeloid Leukemia

University of Hong

University of Hong is a pharma organization headquartered in CN. Primary therapeutic focus areas include Early Childhood Caries, Acute Myeloid Leukemia, Influenza Virus Infection, Smoking Cessation, Influenza. NovaPharma

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
42
Drugs
71
Patents
0
Clinical program

Dexmedetomidine

Approved · small molecule · Anxiety, Separation

Dexmedetomidine for Anxiety, Separation is a Approved program (small_molecule) at The University of Hong Kong with 1 ClinicalTrials.gov record(s).

← All The University of Hong Kong projects Approved small molecule active

Internal code UW 15-105

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
The University of Hong Kong
Phase
Approved
Modality
small_molecule
Indication
Anxiety, Separation
Status
active
Trials
1